(FISI) Financial Institutions - Ratings and Ratios
Checking, Savings, Commercial, Mortgage, Advisory
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 4.56% |
| Yield on Cost 5y | 6.52% |
| Yield CAGR 5y | 3.51% |
| Payout Consistency | 96.3% |
| Payout Ratio | 38.9% |
| Risk via 5d forecast | |
|---|---|
| Volatility | 38.7% |
| Value at Risk 5%th | 52.2% |
| Relative Tail Risk | -18.03% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.82 |
| Alpha | 14.50 |
| CAGR/Max DD | 0.45 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.548 |
| Beta | 0.871 |
| Beta Downside | 1.031 |
| Drawdowns 3y | |
|---|---|
| Max DD | 40.40% |
| Mean DD | 15.51% |
| Median DD | 12.13% |
Description: FISI Financial Institutions December 27, 2025
Financial Institutions, Inc. (NASDAQ:FISI) operates as a full-service regional bank headquartered in Warsaw, New York, offering a suite of consumer, commercial, and municipal banking products. Its portfolio includes checking and savings accounts, money-market and CD offerings, a range of loan products-from residential mortgages and home-equity lines to commercial term loans and equipment financing-and wealth-management services such as investment advisory and retirement plan consulting. The firm also owns a real-estate investment trust (REIT) that holds residential mortgage and commercial-loan assets.
Key recent metrics underscore its positioning: FY 2023 net interest income rose 6% year-over-year to $210 million, while the loan-to-deposit ratio stabilized at 78%, reflecting prudent balance-sheet management. The bank’s net interest margin (NIM) sits at 3.1%, marginally above the regional-bank average, and its loan growth is driven largely by New York’s commercial-real-estate sector, which remains sensitive to Federal Reserve rate policy and state-level employment trends.
For a deeper, data-rich view of FISI’s valuation dynamics, you may find ValueRay’s analytical platform a useful next step.
Piotroski VR‑10 (Strict, 0-10) 1.0
| Net Income (-27.9m TTM) > 0 and > 6% of Revenue (6% = 16.0m TTM) |
| FCFTA 0.00 (>2.0%) and ΔFCFTA 0.44pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -1958 % (prev -1146 %; Δ -812.1pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.00 (>3.0%) and CFO 24.4m > Net Income -27.9m (YES >=105%, WARN >=100%) |
| NO Net Debt/EBITDA fails (EBITDA <= 0) |
| Current Ratio 0.04 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (20.3m) change vs 12m ago 30.06% (target <= -2.0% for YES) |
| Gross Margin 42.94% (prev 52.66%; Δ -9.72pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 4.29% (prev 6.00%; Δ -1.71pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio -0.35 (EBITDA TTM -40.3m / Interest Expense TTM 137.1m) >= 6 (WARN >= 3) |
Altman Z'' -5.21
| (A) -0.83 = (Total Current Assets 211.7m - Total Current Liabilities 5.43b) / Total Assets 6.29b |
| (B) 0.07 = Retained Earnings (Balance) 423.8m / Total Assets 6.29b |
| (C) -0.01 = EBIT TTM -47.9m / Avg Total Assets 6.22b |
| (D) 0.07 = Book Value of Equity 387.2m / Total Liabilities 5.67b |
| Total Rating: -5.21 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 33.94
| 1. Piotroski 1.0pt |
| 2. FCF Yield 3.61% |
| 3. FCF Margin 9.00% |
| 4. Debt/Equity 0.33 |
| 5. Debt/Ebitda -0.40 |
| 6. ROIC - WACC (= -15.08)% |
| 7. RoE -4.69% |
| 8. Rev. Trend -16.29% |
| 9. EPS Trend -31.23% |
What is the price of FISI shares?
Over the past week, the price has changed by +5.42%, over one month by +4.04%, over three months by +26.23% and over the past year by +27.30%.
Is FISI a buy, sell or hold?
- Strong Buy: 0
- Buy: 2
- Hold: 0
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the FISI price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 34.5 | 3.7% |
| Analysts Target Price | 34.5 | 3.7% |
| ValueRay Target Price | 36.5 | 9.9% |
FISI Fundamental Data Overview January 19, 2026
P/B = 1.0721
P/EG = 1.91
Revenue TTM = 266.7m USD
EBIT TTM = -47.9m USD
EBITDA TTM = -40.3m USD
Long Term Debt = 115.0m USD (from longTermDebt, last quarter)
Short Term Debt = 55.0m USD (from shortTermDebt, last quarter)
Debt = 202.1m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 16.2m USD (from netDebt column, last quarter)
Enterprise Value = 664.2m USD (648.0m + Debt 202.1m - CCE 185.9m)
Interest Coverage Ratio = -0.35 (Ebit TTM -47.9m / Interest Expense TTM 137.1m)
EV/FCF = 27.66x (Enterprise Value 664.2m / FCF TTM 24.0m)
FCF Yield = 3.61% (FCF TTM 24.0m / Enterprise Value 664.2m)
FCF Margin = 9.00% (FCF TTM 24.0m / Revenue TTM 266.7m)
Net Margin = -10.47% (Net Income TTM -27.9m / Revenue TTM 266.7m)
Gross Margin = 42.94% ((Revenue TTM 266.7m - Cost of Revenue TTM 152.2m) / Revenue TTM)
Gross Margin QoQ = 63.11% (prev 60.78%)
Tobins Q-Ratio = 0.11 (Enterprise Value 664.2m / Total Assets 6.29b)
Interest Expense / Debt = 16.14% (Interest Expense 32.6m / Debt 202.1m)
Taxrate = 18.86% (4.76m / 25.2m)
NOPAT = -38.9m (EBIT -47.9m * (1 - 18.86%)) [loss with tax shield]
Current Ratio = 0.04 (Total Current Assets 211.7m / Total Current Liabilities 5.43b)
Debt / Equity = 0.33 (Debt 202.1m / totalStockholderEquity, last quarter 621.7m)
Debt / EBITDA = -0.40 (negative EBITDA) (Net Debt 16.2m / EBITDA -40.3m)
Debt / FCF = 0.67 (Net Debt 16.2m / FCF TTM 24.0m)
Total Stockholder Equity = 595.6m (last 4 quarters mean from totalStockholderEquity)
RoA = -0.45% (Net Income -27.9m / Total Assets 6.29b)
RoE = -4.69% (Net Income TTM -27.9m / Total Stockholder Equity 595.6m)
RoCE = -6.74% (EBIT -47.9m / Capital Employed (Equity 595.6m + L.T.Debt 115.0m))
RoIC = -5.01% (negative operating profit) (NOPAT -38.9m / Invested Capital 775.7m)
WACC = 10.07% (E(648.0m)/V(850.2m) * Re(9.12%) + D(202.1m)/V(850.2m) * Rd(16.14%) * (1-Tc(0.19)))
Discount Rate = 9.12% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 14.50%
[DCF Debug] Terminal Value 61.51% ; FCFF base≈24.0m ; Y1≈15.8m ; Y5≈7.19m
Fair Price DCF = 4.36 (EV 103.9m - Net Debt 16.2m = Equity 87.7m / Shares 20.1m; r=10.07% [WACC]; 5y FCF grow -40.0% → 2.90% )
[DCF Warning] FCF declining rapidly (-40.0%), DCF may be unreliable
EPS Correlation: -31.23 | EPS CAGR: -48.46% | SUE: -3.96 | # QB: 0
Revenue Correlation: -16.29 | Revenue CAGR: 16.02% | SUE: 0.61 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.88 | Chg30d=-0.060 | Revisions Net=-2 | Analysts=1
EPS next Year (2026-12-31): EPS=3.84 | Chg30d=-0.090 | Revisions Net=-1 | Growth EPS=+7.6% | Growth Revenue=+5.5%
Additional Sources for FISI Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle